Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,122 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesäniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M; FIELD study investigators. Keech A, et al. Among authors: Sullivan D. Lancet. 2005 Nov 26;366(9500):1849-61. doi: 10.1016/S0140-6736(05)67667-2. Lancet. 2005. PMID: 16310551 Clinical Trial.
Effect of orlistat on cardiovascular disease risk in obese adults.
Swinburn BA, Carey D, Hills AP, Hooper M, Marks S, Proietto J, Strauss BJ, Sullivan D, Welborn TA, Caterson ID. Swinburn BA, et al. Among authors: Sullivan D. Diabetes Obes Metab. 2005 May;7(3):254-62. doi: 10.1111/j.1463-1326.2004.00467.x. Diabetes Obes Metab. 2005. PMID: 15811142 Clinical Trial.
Participants (n = 339) from eight centres in Australia and New Zealand were randomized to either orlistat (120 mg) three times daily (n = 104 women, 66 men; mean +/- s.d. age = 52.0 +/- 7.5 years, body mass index (BMI) = 37.6 +/- 5.1 kg/m(2)) or placebo three times daily (n = 89 women, 80 men; age = 52.5 +/- 7.4 years, BMI = 38.0 +/- 4.9 kg/m(2)). ...
Participants (n = 339) from eight centres in Australia and New Zealand were randomized to either orlistat (120 mg) three times daily (n = 10 …
Effects of canagliflozin on body weight and relationship to HbA1c and blood pressure changes in patients with type 2 diabetes.
Cefalu WT, Stenlöf K, Leiter LA, Wilding JP, Blonde L, Polidori D, Xie J, Sullivan D, Usiskin K, Canovatchel W, Meininger G. Cefalu WT, et al. Among authors: Sullivan D. Diabetologia. 2015 Jun;58(6):1183-7. doi: 10.1007/s00125-015-3547-2. Epub 2015 Mar 27. Diabetologia. 2015. PMID: 25813214 Free PMC article. Clinical Trial.
Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin.
Bilezikian JP, Watts NB, Usiskin K, Polidori D, Fung A, Sullivan D, Rosenthal N. Bilezikian JP, et al. Among authors: Sullivan D. J Clin Endocrinol Metab. 2016 Jan;101(1):44-51. doi: 10.1210/jc.2015-1860. Epub 2015 Nov 18. J Clin Endocrinol Metab. 2016. PMID: 26580234 Free PMC article. Clinical Trial.
Tenth Triennial Toxicology Salary Survey.
Sullivan DW Jr, Gad SC. Sullivan DW Jr, et al. Among authors: Sullivan DW. Int J Toxicol. 2020 Mar 17:1091581820910378. doi: 10.1177/1091581820910378. Online ahead of print. Int J Toxicol. 2020. PMID: 32180480
Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 Study.
Sukkar L, Kang A, Hockham C, Young T, Jun M, Foote C, Pecoits-Filho R, Neuen B, Rogers K, Pollock C, Cass A, Sullivan D, Wong G, Knight J, Peiris D, Gallagher M, Jardine M; EXTEND45 Study Steering Committee. Sukkar L, et al. Among authors: Sullivan D. Diabetes Care. 2020 Mar 11:dc191803. doi: 10.2337/dc19-1803. Online ahead of print. Diabetes Care. 2020. PMID: 32161053
2,122 results
Jump to page
Feedback